April 2007

Dementia Insights

Business Advisor

Previous Article

Editor's Message

Next Article

This Month's Issue

Neuromuscular Notes: Taking the Mis- out of CIDP Diagnosis

Karissa Gable, MD

Point/Counterpoint: Food and Drug Administration Multiple Sclerosis Categorization Changes

Svetlana Primma Eckert, MD; Bianca Weinstock-Guttman, MD; and Stephen Krieger, MD

Drugs in Development for Multiple Sclerosis

Konstantin Balashov, MD, PhD

February 2020 cover

Full Issue